We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Barr Plans Generic Thalomid; Celgene Plans Lawsuit
Armed with several production and method-of-use patents to cover its cancer drug Thalomid, Celgene said it is preparing a legal challenge to head off Barr Laboratories’ move to market thalidomide, a generic version of the drug, company executives said.